Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Injection in the Management of Thumb Carpometacarpal Arthritis: a Randomized Controlled Trial

NCT05990881 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT05990881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05990881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Injection in the Management of Thumb Carpometacarpal Arthritis: a Randomized Controlled Trial
Lead sponsor
Rhode Island Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
August 27, 2023
Completion date
July 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carpometacarpal sprain, clostridium; botulinum, thumb sprain